Today we’re getting under the hood with Jessica Federer a daughter, sister, friend, women’s advocate, board member, big pharma executive, managing director, and investor adept at deploying technology to make meaningful advancements for both business and society.
She serves on the boards of Sage Therapeutics, Pluto Health, and Angelini Ventures. She was one of the first Chief Digital Officers for the life sciences industry, leading the global digital transformation for Bayer A.G. across the Pharmaceutical, Consumer Care, Crop Science, and Animal Health businesses. Her data-focused career includes regulatory, market access, record-breaking product launches, and enterprise readiness. After almost a decade in Germany, Jessica returned to the US and advised both Fortune Global 100 companies and industry-disrupting start-ups on digital innovation across the life sciences continuum.
During the pandemic, she joined Europe’s fastest-growing digital health company, Huma, as Managing Director / US CEO, establishing a U.S. team and expanding into decentralized clinical trials for international Covid-19 vaccine studies. Jessica is recognized as a 2023 “Icon” by Rock Health, one of the top 100 CDOs, and a leading health tech influencer. She is the founder and chair of the NYSE Women’s Health Investor Summit, bringing together investors representing over 100 billion USD. She serves on the Yale Ventures Blavatnik board, and the Yale IRB, and previously was on the United Nations ITU advisory board, and the BHP Technology Advisory Board.
Jessica began her public health career as an analyst at the Agency for Healthcare Research and Quality in the US Department of Health and Human Services. She earned a Bachelor of Science from George Washington University and a Master of Public Health from Yale.
Previous
Next
Dr. Rachael B.
If you haven’t already, please give us a quick review and rating on Apple podcasts and Spotify and don’t forget you can follow us FaceBook, Instagram, Twitter and YouTube.